InvestorsHub Logo
Followers 94
Posts 11181
Boards Moderated 0
Alias Born 11/02/2003

Re: stockmarkot post# 5040

Wednesday, 09/10/2014 10:05:06 PM

Wednesday, September 10, 2014 10:05:06 PM

Post# of 24335

It is anticipated that preliminary human trials for the Vantage Health Sensor will begin next month at Scripps Translational Science Institute, paid for by a BioPharma partner of the Company. Mr. Barbera will continue to be Chairman and CEO of Nanobeak, which is the private company majority shareholder of Vantage Health

Read more: http://www.benzinga.com/pressreleases/14/07/b4738833/dr-kevin-buckman-named-chairman-and-ceo-of-vantage-health#ixzz3Cy6oxxxH